A randomized, double-blind comparison of atomoxetine hydrochloride and placebo in child and adolescent outpatients with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder [ODD]

Trial Profile

A randomized, double-blind comparison of atomoxetine hydrochloride and placebo in child and adolescent outpatients with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder [ODD]

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2008

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder; Behavioural disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2008 Last checked against ClinicalTrials.gov record on 29 Sep 2008.
    • 01 Feb 2008 Results have been published (1096613)
    • 27 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top